Cargando…

Early prediction of histopathological response of rectal tumors after one week of preoperative radiochemotherapy using (18) F-FDG PET-CT imaging. A prospective clinical study

BACKGROUND: Preoperative radiochemotherapy (RCT) is standard in locally advanced rectal cancer (LARC). Initial data suggest that the tumor’s metabolic response, i.e. reduction of its (18) F-FDG uptake compared with the baseline, observed after two weeks of RCT, may correlate with histopathological r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Goldberg, Natalia, Kundel, Yulia, Purim, Ofer, Bernstine, Hanna, Gordon, Noa, Morgenstern, Sara, Idelevich, Efraim, Wasserberg, Nir, Sulkes, Aaron, Groshar, David, Brenner, Baruch
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3447722/ https://www.ncbi.nlm.nih.gov/pubmed/22853868 http://dx.doi.org/10.1186/1748-717X-7-124

Ejemplares similares

Restaging locally advanced rectal cancer by different imaging modalities after preoperative chemoradiation: a comparative study
por: Dickman, Ram, et al.
Publicado: (2013)

Sphincter preservation in distal CT2N0 rectal cancer after preoperative chemoradiotherapy
por: Wasserberg, Nir, et al.
Publicado: (2014)

Early prediction of residual disease after neoadjuvant chemoradiotherapy and cetuximab for locally advanced esophageal cancer using (18)F-FDG PET-CT imaging: a prospective cohort study
por: Brenner, Baruch, et al.
Publicado: (2022)

A Phase Ib/II Study Evaluating the Combination of Weekly Docetaxel and Cisplatin Together with Capecitabine and Bevacizumab in Patients with Advanced Esophago-Gastric Cancer
por: Brenner, Baruch, et al.
Publicado: (2016)

Baseline 18F-FDG PET/CT as predictor of the pathological response to neoadjuvant therapy in esophageal cancer: A retrospective study
por: Domachevsky, Liran, et al.
Publicado: (2018)

Early PET‐CT in patients with pathological stage III colon cancer may improve their outcome: Results from a large retrospective study
por: Moore, Assaf, et al.
Publicado: (2018)

Postoperative chemoradiation for resected gastric cancer - is the Macdonald Regimen Tolerable? a retrospective multi-institutional study
por: Kundel, Yulia, et al.
Publicado: (2011)

Octogenarian patients with colorectal cancer: Characterizing an emerging clinical entity
por: Goldvaser, Hadar, et al.
Publicado: (2017)

Esophageal Cancer in Israel has Unique Clinico-Pathological Features: A Retrospective Study
por: Sarfaty, Michal, et al.
Publicado: (2017)

Cancer of the colon and rectum: Potential effects of sex-age interactions on incidence and outcome
por: Purim, Ofer, et al.
Publicado: (2013)

Phase II Study of Concurrent Capecitabine and External Beam Radiotherapy for Pain Control of Bone Metastases of Breast Cancer Origin
por: Kundel, Yulia, et al.
Publicado: (2013)

18F-FDG PET/MR imaging of lymphoma nodal target lesions: Comparison of PET standardized uptake value (SUV) with MR apparent diffusion coefficient (ADC)
por: Bernstine, Hanna, et al.
Publicado: (2018)

Correlation of 18F-FDG PET/MRE Metrics with Inflammatory Biomarkers in Patients with Crohn's Disease: A Pilot Study
por: Domachevsky, Liran, et al.
Publicado: (2017)

Reproducibility and repeatability of same-day two sequential FDG PET/MR and PET/CT
por: Groshar, David, et al.
Publicado: (2017)

Hepatic 18F-FDG Uptake Measurements on PET/MR: Impact of Volume of Interest Location on Repeatability
por: Domachevsky, Liran, et al.
Publicado: (2017)

Biological predictive factors in rectal cancer treated with preoperative radiotherapy or radiochemotherapy
por: Negri, F V, et al.
Publicado: (2008)

Assessment of response to neoadjuvant radiochemotherapy with F-18 FLT and F-18 FDG PET/CT in patients with rectal cancer
por: Rendl, Gundula, et al.
Publicado: (2014)

Predictive Factors of the Response of Rectal Cancer to Neoadjuvant Radiochemotherapy
por: Spolverato, Gaya, et al.
Publicado: (2011)

Prognostic Significance of Tumor Regression in Locally Advanced Rectal Cancer after Preoperative Radiochemotherapy
por: Omejc, Mirko, et al.
Publicado: (2017)

Intensified neoadjuvant radiochemotherapy for rectal cancer enhances surgical complications
por: Schiffmann, Leif, et al.
Publicado: (2013)

Influence of Gender on Radiosensitivity during Radiochemotherapy of Advanced Rectal Cancer
por: Schuster, Barbara, et al.
Publicado: (2021)

Dynamic (11)C-Choline PET / CT for the primary diagnosis of prostate cancer
por: Golan, Shay, et al.
Publicado: (2018)

Efficacy of immune‐checkpoint inhibitors in metastatic gastric or gastroesophageal junction adenocarcinoma by patient subgroups: A systematic review and meta‐analysis
por: Kundel, Yulia, et al.
Publicado: (2020)

Detection of morphologic alterations in rectal carcinoma following preoperative radiochemotherapy based on multiphoton microscopy imaging
por: Li, Lianhuang, et al.
Publicado: (2015)

Identification of potential metabolic biomarkers of rectal cancer and of the effect of neoadjuvant radiochemotherapy
por: Rodríguez-Tomàs, Elisabet, et al.
Publicado: (2021)

Radiochemotherapy
Publicado: (1998)

Association Between the Cytogenetic Profile of Tumor Cells and Response to Preoperative Radiochemotherapy in Locally Advanced Rectal Cancer
por: González-González, María, et al.
Publicado: (2014)

Prognostic value of the micronucleus assay for clinical endpoints in neoadjuvant radiochemotherapy for rectal cancer
por: Dröge, Leif Hendrik, et al.
Publicado: (2021)

Phase II trial of preoperative radiochemotherapy with concurrent bevacizumab, capecitabine and oxaliplatin in patients with locally advanced rectal cancer
por: Dellas, Kathrin, et al.
Publicado: (2013)

Biomarker-Driven Therapy in Metastatic Gastric and Esophageal Cancer: Real-Life Clinical Experience
por: Purim, Ofer, et al.
Publicado: (2018)

A Systematic Review of the Cyclooxygenase-2 (COX-2) Expression in Rectal Cancer Patients Treated with Preoperative Radiotherapy or Radiochemotherapy
por: Berbecka, Monika, et al.
Publicado: (2021)

Preoperative Radiochemotherapy in Rectal Cancer: Is There an Impact of Oxaliplatin on Pathologic Complete Response and Survival Rates under “Real World“ Conditions?
por: Grabenbauer, Alexander, et al.
Publicado: (2023)

Proteomic analysis to identify markers for response to neoadjuvant treatment in esophageal and gastroesophageal cancer
por: Zlotnik, Oran, et al.
Publicado: (2021)

Effect of radiochemotherapy on T2* MRI in HNSCC and its relation to FMISO PET derived hypoxia and FDG PET
por: Wiedenmann, Nicole, et al.
Publicado: (2018)

Treatment outcome after radiochemotherapy in anal cancer patients staged with (18)F-FDG-PET-CT
por: Braun, L.H., et al.
Publicado: (2020)

Neoadjuvant radiochemotherapy in the treatment of fixed and semi-fixed rectal tumors. Analysis of results and prognostic factors
por: Ferrigno, Robson, et al.
Publicado: (2006)

Possible contribution of IMRT in postoperative radiochemotherapy for rectal cancer: analysis on 1798 patients by prediction model
por: Liu, Wen-Yang, et al.
Publicado: (2016)

Anastomotic Breakdown Five Years After Neoadjuvant Radiochemotherapy and Ultralow Anterior Resection for Rectal Adenocarcinoma
por: Nguyen, Eric, et al.
Publicado: (2020)

Evaluation of Efficacy and Tolerance of Radical Radiotherapy and Radiochemotherapy in Treatment of Locally Advanced, Unresectable Rectal Cancer
por: Kraszkiewicz, M., et al.
Publicado: (2022)

Stage II/III rectal cancer with intermediate response to preoperative radiochemotherapy: Do we have indications for individual risk stratification?
por: Sprenger, Thilo, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_8j5gffsirbrchrqjki2n7fg3i3